Genomic characteristics of hepatocellular carcinoma patients with response to sorafenib

被引：0
|
作者：
Yim, Sun Young [1 ]
Kang, Sang-Hee [1 ]
Lee, Young-Sun [1 ]
Lee, Yoonseok [1 ]
Lim, Ji-Hwan [1 ]
Kim, Tae Hyung [1 ]
Jung, Young Kul [1 ]
Seo, Yeon Seok [1 ]
Yim, Hyung Joon [1 ]
Yeon, Jong Eun [1 ]
Lee, Ju-Seog [2 ]
Kim, Ji Hoon [1 ]
机构：
[1] Korea Univ Hosp, Seoul, South Korea
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-121
引用
下载
收藏
页码：S578 / S578
页数：1
相关论文
共 50 条
  • [21] Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks
    Kanthaje, Shruthi
    Makol, Ankita
    Chakraborti, Anuradha
    HEPATOLOGY RESEARCH, 2018, 48 (01) : 5 - 14
  • [22] Sorafenib in Hepatocellular Carcinoma
    Bajetta, Emilio
    Procopio, Giuseppe
    Colombo, Andrea
    Guadalupi, Valentina
    Verzoni, Elena
    Pietrantonio, Filippo
    Pusceddu, Sara
    Manzoni, Mariangela
    Gevorgyan, Arpine
    Buzzoni, Roberto
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 277 - 287
  • [23] Sorafenib in hepatocellular carcinoma
    Josephs, Debra H.
    Ross, Paul J.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (08) : 451 - 456
  • [24] Sorafenib - In hepatocellular carcinoma
    Simpson, Dene
    Keating, Gillian M.
    DRUGS, 2008, 68 (02) : 251 - 258
  • [25] Morphological and Molecular Characteristics of Skin Tumors in Hepatocellular Carcinoma Patients under Sorafenib Treatment
    Fuster, Carla
    Da Fonseca, Leonardo
    Sapena, Victor
    Diaz-Gonzalez, Alvaro
    Boix, Loreto
    Sanduzzi-Zamparelli, Marco
    Samper, Esther
    Llarch, Neus
    Iserte, Gemma
    Torres, Ferran
    Sole, Manel
    Bruix, Jordi
    Reig, Maria
    Diaz, Alba
    MODERN PATHOLOGY, 2019, 32
  • [26] Morphological and Molecular Characteristics of Skin Tumors in Hepatocellular Carcinoma Patients under Sorafenib Treatment
    Fuster, Carla
    Da Fonseca, Leonardo
    Sapena, Victor
    Diaz-Gonzalez, Alvaro
    Boix, Loreto
    Sanduzzi-Zamparelli, Marco
    Samper, Esther
    Llarch, Neus
    Iserte, Gemma
    Torres, Ferran
    Sole, Manel
    Bruix, Jordi
    Reig, Maria
    Diaz, Alba
    LABORATORY INVESTIGATION, 2019, 99
  • [27] Association of SLC15A2 genomic variation with the response to sorafenib treatment: Whole-genome analysis in patients with hepatocellular carcinoma
    Kim, Bo Hyun
    Lee, Yeon-Su
    Kim, Byung Chul
    Shin, Aesun
    Kim, Jin Sook
    Hong, Seung-Hyun
    Hwang, Jung-Ah
    Lee, Jung Ahn
    Nam, Seungyoon
    Lee, Sung Hoon
    Bhak, Jong
    Park, Joong-Won
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [28] Multicenter retrospective analysis of clinical predictors of response to sorafenib in patients with hepatocellular carcinoma.
    Lulla, P. D.
    Brammer, J. E.
    Bandeali, S. J.
    Lynch, G. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Influence of underlying liver disease on response to sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Bouattour, M.
    Faivre, S. J.
    Dreyer, C.
    Paradis, V.
    Raymond, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [30] Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
    Personeni, Nicola
    Bozzarelli, Silvia
    Pressiani, Tiziana
    Rimassa, Lorenza
    Tronconi, Maria Chiara
    Sclafani, Francesco
    Carnaghi, Carlo
    Pedicini, Vittorio
    Giordano, Laura
    Santoro, Armando
    JOURNAL OF HEPATOLOGY, 2012, 57 (01) : 101 - 107
12345